With regard to liver diseases, plasma PTX3 was indicated to be associated with nonalcoholic steatohepatitis (NASH)30 and could differentiate NASH from non-NASH31. This evidence concerns the gene PTX3 and metabolic dysfunction-associated steatohepatitis.